Floating Covers
Floating Covers market is segmented by region (country), players, by Type and by Application. Pla ... Read More
Global and United States Urology Drugs Market Report & Forecast 2023-2028
1 Study Coverage
1.1 Urology Drugs Product Introduction
1.2 Global Urology Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Urology Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Urology Drugs Sales in Volume for the Year 2017-2028
1.3 United States Urology Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Urology Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Urology Drugs Sales in Volume for the Year 2017-2028
1.4 Urology Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Urology Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Urology Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Urology Drugs Market Dynamics
1.5.1 Urology Drugs Industry Trends
1.5.2 Urology Drugs Market Drivers
1.5.3 Urology Drugs Market Challenges
1.5.4 Urology Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Urology Drugs Market Segment by Type
2.1.1 Α (alpha) Blockers
2.1.2 5 α-reductase Inhibitors
2.2 Global Urology Drugs Market Size by Type
2.2.1 Global Urology Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Urology Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Urology Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Urology Drugs Market Size by Type
2.3.1 United States Urology Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Urology Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Urology Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Urology Drugs Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Urology Drugs Market Size by Application
3.2.1 Global Urology Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Urology Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Urology Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Urology Drugs Market Size by Application
3.3.1 United States Urology Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Urology Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Urology Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Urology Drugs Competitor Landscape by Company
4.1 Global Urology Drugs Market Size by Company
4.1.1 Top Global Urology Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Urology Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Urology Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Urology Drugs Price by Manufacturer (2017-2022)
4.2 Global Urology Drugs Concentration Ratio (CR)
4.2.1 Urology Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Urology Drugs in 2021
4.2.3 Global Urology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Urology Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Urology Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Urology Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Urology Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Urology Drugs Market Size by Company
4.5.1 Top Urology Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Urology Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Urology Drugs Sales by Players (2020, 2021 & 2022)
5 Global Urology Drugs Market Size by Region
5.1 Global Urology Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Urology Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Urology Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Urology Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Urology Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Urology Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Urology Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Urology Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Urology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Urology Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Urology Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Urology Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Urology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Urology Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Urology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Urology Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Urology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Astellas
7.1.1 Astellas Corporation Information
7.1.2 Astellas Description and Business Overview
7.1.3 Astellas Urology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Astellas Urology Drugs Products Offered
7.1.5 Astellas Recent Development
7.2 Endo
7.2.1 Endo Corporation Information
7.2.2 Endo Description and Business Overview
7.2.3 Endo Urology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Endo Urology Drugs Products Offered
7.2.5 Endo Recent Development
7.3 GP Pharm
7.3.1 GP Pharm Corporation Information
7.3.2 GP Pharm Description and Business Overview
7.3.3 GP Pharm Urology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 GP Pharm Urology Drugs Products Offered
7.3.5 GP Pharm Recent Development
7.4 Tolmar
7.4.1 Tolmar Corporation Information
7.4.2 Tolmar Description and Business Overview
7.4.3 Tolmar Urology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Tolmar Urology Drugs Products Offered
7.4.5 Tolmar Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Urology Drugs Industry Chain Analysis
8.2 Urology Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Urology Drugs Distributors
8.3 Urology Drugs Production Mode & Process
8.4 Urology Drugs Sales and Marketing
8.4.1 Urology Drugs Sales Channels
8.4.2 Urology Drugs Distributors
8.5 Urology Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Urology Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Urology Drugs Market Trends
Table 3. Urology Drugs Market Drivers
Table 4. Urology Drugs Market Challenges
Table 5. Urology Drugs Market Restraints
Table 6. Global Urology Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Urology Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Urology Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Urology Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Urology Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Urology Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Urology Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Urology Drugs Sales by Manufacturer, (MT), 2017-2022
Table 14. Global Urology Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Urology Drugs Price by Manufacturer (2017-2022) & (USD/Kg)
Table 16. Global Urology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Urology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urology Drugs as of 2021)
Table 18. Top Players of Urology Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Urology Drugs Product Type
Table 20. Date of International Manufacturers Enter into Urology Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Urology Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Urology Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Urology Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Urology Drugs Sales by Players, (MT), 2020, 2021 & 2022
Table 26. United States Urology Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Urology Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Urology Drugs Sales in Volume by Region (2017-2022) & (MT)
Table 29. Global Urology Drugs Sales in Volume Forecast by Region (2023-2028) & (MT)
Table 30. Global Urology Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Urology Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Urology Drugs Sales in Volume by Country (2017-2028) & (MT)
Table 33. North America Urology Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Urology Drugs Sales in Volume by Region (2017-2028) & (MT)
Table 35. Asia Pacific Urology Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Urology Drugs Sales in Volume by Country (2017-2028) & (MT)
Table 37. Europe Urology Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Urology Drugs Sales in Volume by Country (2017-2028) & (MT)
Table 39. Latin Americaa Urology Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Urology Drugs Sales in Volume by Country (2017-2028) & (MT)
Table 41. Middle East and Africa Urology Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Astellas Corporation Information
Table 43. Astellas Description and Business Overview
Table 44. Astellas Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 45. Astellas Urology Drugs Product
Table 46. Astellas Recent Development
Table 47. Endo Corporation Information
Table 48. Endo Description and Business Overview
Table 49. Endo Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 50. Endo Product
Table 51. Endo Recent Development
Table 52. GP Pharm Corporation Information
Table 53. GP Pharm Description and Business Overview
Table 54. GP Pharm Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 55. GP Pharm Product
Table 56. GP Pharm Recent Development
Table 57. Tolmar Corporation Information
Table 58. Tolmar Description and Business Overview
Table 59. Tolmar Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 60. Tolmar Product
Table 61. Tolmar Recent Development
Table 62. Key Raw Materials Lists
Table 63. Raw Materials Key Suppliers Lists
Table 64. Urology Drugs Customers List
Table 65. Urology Drugs Distributors List
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Urology Drugs Product Picture
Figure 2. Global Urology Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Urology Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Urology Drugs Sales 2017-2028 (MT)
Figure 5. United States Urology Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Urology Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Urology Drugs Sales 2017-2028 (MT)
Figure 8. United States Urology Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Urology Drugs Market Share in Global, in Volume (MT) 2017-2028
Figure 10. Urology Drugs Report Years Considered
Figure 11. Product Picture of Α (alpha) Blockers
Figure 12. Product Picture of 5 α-reductase Inhibitors
Figure 13. Global Urology Drugs Market Share by Type in 2022 & 2028
Figure 14. Global Urology Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Urology Drugs Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Urology Drugs Sales by Type (2017-2028) & (MT)
Figure 17. Global Urology Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Urology Drugs Price by Type (2017-2028) & (USD/Kg)
Figure 19. United States Urology Drugs Market Share by Type in 2022 & 2028
Figure 20. United States Urology Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Urology Drugs Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Urology Drugs Sales by Type (2017-2028) & (MT)
Figure 23. United States Urology Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Urology Drugs Price by Type (2017-2028) & (USD/Kg)
Figure 25. Product Picture of Hospital
Figure 26. Product Picture of Clinic
Figure 27. Product Picture of Others
Figure 28. Global Urology Drugs Market Share by Application in 2022 & 2028
Figure 29. Global Urology Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Urology Drugs Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Urology Drugs Sales by Application (2017-2028) & (MT)
Figure 32. Global Urology Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Urology Drugs Price by Application (2017-2028) & (USD/Kg)
Figure 34. United States Urology Drugs Market Share by Application in 2022 & 2028
Figure 35. United States Urology Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Urology Drugs Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Urology Drugs Sales by Application (2017-2028) & (MT)
Figure 38. United States Urology Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Urology Drugs Price by Application (2017-2028) & (USD/Kg)
Figure 40. North America Urology Drugs Sales in Volume Growth Rate 2017-2028 (MT)
Figure 41. North America Urology Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Urology Drugs Sales in Volume Growth Rate 2017-2028 (MT)
Figure 45. Europe Urology Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Urology Drugs Sales in Volume Growth Rate 2017-2028 (MT)
Figure 52. Asia-Pacific Urology Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Urology Drugs Sales in Volume Growth Rate 2017-2028 (MT)
Figure 64. Latin America Urology Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Urology Drugs Sales in Volume Growth Rate 2017-2028 (MT)
Figure 69. Middle East & Africa Urology Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. U.A.E Urology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Urology Drugs Value Chain
Figure 74. Urology Drugs Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Astellas Endo GP Pharm Tolmar